Camp4 Therapeutics (CAMP) Accumulated Depreciation & Amortization (2023 - 2026)

Camp4 Therapeutics has disclosed Accumulated Depreciation & Amortization across 4 years of filings, most recently posting $500000.0 for Q1 2026.

• Accumulated Depreciation & Amortization for Q1 2026 came in at $500000.0, up 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (up 25.0% YoY), and the FY2025 annual result was $1.6 million, down 5.88% from the prior year.
• Accumulated Depreciation & Amortization came in at $500000.0 for Q1 2026 at Camp4 Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.7 million in Q4 2024 to a low of $400000.0 in Q1 2025.
• The 4-year median for Accumulated Depreciation & Amortization is $900000.0 (2024), against an average of $999272.7.
• Across the five-year window, Accumulated Depreciation & Amortization slumped 68.7% in 2025 and climbed 25.0% in 2026, its largest moves.
• Camp4 Therapeutics' Accumulated Depreciation & Amortization stood at $1.7 million in 2023, then gained by 1.31% to $1.7 million in 2024, then retreated by 5.88% to $1.6 million in 2025, then tumbled by 68.75% to $500000.0 in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $500000.0 (Q1 2026), $1.6 million (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.